Wikipedia -WSS

Wikipedia

author：explore 2025-08-10 11:42:46 - browse：3

LONDON — AstraZeneca said on Monday that a new lung cancer treatment outperformed standard-of-care chemotherapy in a trial, but investors found the results less impressive than anticipated, sending company shares down in early trading.

Based on an interim analysis of a Phase 3 trial, the company said that the drug, datopotamab deruxtecan, led to improvement in progression-free survival in patients non-small cell lung cancer, a primary endpoint of the study. There was also a positive early trend on overall survival, with Susan Galbraith, AstraZeneca’s oncology leader, describing the results as “compelling evidence for the potential role” that the drug could play for patients.

But investors had been hoping for a clearer signal of benefit. Analysts noted that despite the success in progression-free survival, it was not described as a “clinically meaningful” improvement, which, as J.P. Morgan analysts wrote, “we believe the market would have liked to have seen.”

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： New air purifier tech could be key to improving indoor air quality
Next article： Oprah kicked off a national conversation on obesity. Let's have it

leisure time

WSS

What Congress can do to address the rural doctor shortage

Biotech stock slump in 2023: awaiting the turnaround

There's no autism epidemic. It's an autism diagnosis epidemic

There's no autism epidemic. It's an autism diagnosis epidemic

AstraZeneca, Daiichi breast cancer treatment succeeds in trial

Washington mulls new rules to avert another Change Healthcare

Wikipedia

Wikipedia

entertainment

Anesthesiologist group: stop taking Ozempic before surgery

EpiPen alternative approval delay highlights citizen petition issue

Medicare proposal to cover medical devices draws a mixed reaction

Merck drug for rare lung condition set for approval in U.S.

As demand for Covid shots wanes, Moderna seeks its next success

Abortion pill Supreme Court ruling could impact entire drug industry

Heart attack and stroke risk calculators need revising

Vertex Pharmaceuticals may move headquarters in Boston

Malaria cases in Florida and Texas: Here’s what you need to know

EpiPen alternative approval delay highlights citizen petition issue

leisure time

Biotech lab space demand falls sharply

It's been 20 years since Dolly the sheep. Where's my clone?

Readout Newsletter: WuXi and Congress, Boundless Bio, etc.

Second xenotransplant done with gene

Food as medicine: Medically tailored meals may get standardized

Abortion pill case raises question: who can sue the FDA?

hotspot

focus

leisure time

leisure time